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http://dx.doi.org/10.1016/j.stemcr.2017.01.012SUMMARYThe truncatedmutant form of the chargedmultivesicular body protein 2B (CHMP2B) is causative for frontotemporal dementia linked to
chromosome 3 (FTD3). CHMP2B is a constituent of the endosomal sorting complex required for transport (ESCRT) and, when mutated,
disrupts endosome-to-lysosome trafficking and substrate degradation. To understand the underlying molecular pathology, FTD3 patient
induced pluripotent stem cells (iPSCs) were differentiated into forebrain-type cortical neurons. FTD3 neurons exhibited abnormal endo-
somes, as previously shown in patients. Moreover, mitochondria of FTD3 neurons displayed defective cristae formation, accompanied by
deficiencies inmitochondrial respiration and increased levels of reactive oxygen. In addition, we provide evidence for perturbed iron ho-
meostasis, presenting an in vitro patient-specific model to study the effects of iron accumulation in neurodegenerative diseases. All phe-
notypes observed in FTD3 neurons were rescued in CRISPR/Cas9-edited isogenic controls. These findings illustrate the relevance of our
patient-specific in vitro models and open up possibilities for drug target development.INTRODUCTION
Frontotemporal dementia (FTD) is the second most com-
mon form of early-onset (<65 years) dementia, accounting
for 5%–8% of total dementia cases. FTD is a neurodegener-
ative disorder with cognitive impairment affecting the
frontal and/or temporal lobes of the brain associated with
progressive brain atrophy (Rossor et al., 2010). FTD is clin-
ically, neuropathologically, and genetically heterogeneous.
One gene affected in familial cases is the charged multive-
sicular body protein 2B (CHMP2B) located on chromosome
3 (FTD3). Patients display global cortical and central brain
atrophies, with no apparent amyloid plaque formation or
conclusive hyperphosphorylated tau aggregates (Isaacs
et al., 2011). Early behavioral changes include apathy, rest-
lessness, disinhibition, and hyperorality. Late-stage behav-
ioral changes include stereotype behavior, mutism, and
dystonia (Isaacs et al., 2011). CHMP2B is a component of
the endosomal sorting complex required for transport III648 Stem Cell Reports j Vol. 8 j 648–658 j March 14, 2017 j ª 2017 The Aut
This is an open access article under the CC BY-NC-ND license (http://creativ(ESCRT-III) complex, which facilitates recycling or degrada-
tion of cell surface receptors (Chassefeyre et al., 2015). As
such, the FTD3-causing mutation of CHMP2B affects func-
tionality of the endosome. Mouse andDrosophila FTD3 an-
imal models have yielded valuable in vivo insights into the
dysfunction of the endosomal lysosomal system and path-
ologic progression (Ahmad et al., 2009; Ghazi-Noori et al.,
2012). However, transgene integration and species-specific
differencesmay contribute to observed phenotypes in such
models. Hence, there is an emerging need for human FTD3
models. In addition, studying how CHMP2B, as a rare mu-
tation, contributes to neurodegenerative disorders has not
yet attracted broader attention. Consequently, a CHMP2B
mutant cellular model could provide further insights into
common underlying dysfunction of biological pathways,
disrupted or disturbed in neurodegenerative diseases and
thereby linking different forms of neurodegeneration.
The availability of viable neurons from patient brains, at
least in part, limits the investigation of the mechanism ofhor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
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neurodegenerative pathogenesis. In this context, human-
induced pluripotent stem cells (iPSCs) provide invaluable
access to study the disease progression in neurons derived
from patient iPSCs and facilitate the development of new
therapies (Ehrlich et al., 2015; Rasmussen et al., 2014).
Meanwhile, recent advances of state-of-the-art genome en-
gineering technique CRISPR/Cas9 (Ran et al., 2013) have
had a tremendous impact allowing for gene correction in
patients who are carriers of disease-causing single-point
mutations. Such genetically edited iPSCs are ideal isogenic
controls for the patient-derived iPSCs, allowing to precisely
dissect the significance of the disease-causing mutation
while maintaining the patient’s own genetic background.
To study the cellular and molecular events of FTD3,
we derived a disease model using human iPSCs from
patients carrying the 31449G > C mutation in CHMP2B
and isogenic controls generated via the CRISPR/Cas9
system with subsequent in vitro neuronal differentiation.
Our model not only confirmed partly prior-observed
pathologies in animal models such as endosome dysregu-
lation (Ghazi-Noori et al., 2012), but also revealed addi-
tional disease-relevant phenotypes in FTD3 by way of
abnormal mitochondrial ultrastructure and function.
Moreover, RNA sequencing (RNA-seq) uncovered that
the CHMP2B mutation manifests in dysregulated expres-
sion of key genes associated with Parkinson’s disease (PD)
and Alzheimer’s disease (AD) and indicated that per-
urbed iron homeostasis is one of the underlying disease
mechanisms.RESULTS
Generation of FTD3 iPSCs and Genetically Corrected
Isogenic Controls
Skin fibroblasts from two symptomatic FTD3 patients
(H150 and H151) and one presymptomatic FTD3 patient
(H242)were reprogrammedusingnon-integrative episomal
plasmids. All of these individuals are from the same family,
and one independent healthy control from an unrelated
family was also included. Individual FTD3 iPSC lines were
assessed for pluripotency features via qPCR (Figure S1A)Figure 1. Gene Correction of FTD3 iPSCs, In Vitro Neuronal Differ
(A) CRISPR/Cas9-mediated gene correction of CHMP2B 31449G > C, s
tification of CHMP2B mutant and wild-type mRNA transcripts. The ex
expression values of wild-type which was set to 100%.
(B) Schematic of neuronal differentiation protocol (see Experiment
fibroblast growth factor; GDNF, glial cell line-derived neurotrophic fa
(C) Quantification of TUJ1, VGlut1, and FOXG1 mRNA expression le
(H150 ISO, H151 ISO, H242 ISO). n = 3 with three replicates in each ex
lines.
(D) Morphometric analyses in FTD3 neurons and isogenic controls: Aver
experiment, significant differences are indicated by *p < 0.05 and **
650 Stem Cell Reports j Vol. 8 j 648–658 j March 14, 2017and immunocytochemistry (ICC) (Figure S1B). Assessment
of pluripotencypotentialwas confirmedvia embryoidbody
formation and subsequent spontaneous differentiation
(Figure S1C). The FTD3-causing mutation 31449G > C
(located at the splice acceptor site inCHMP2B, at the border
of intron 5 and exon 6) was repaired in the FTD3 iPSC lines
using the CRISPR/Cas9 system (Figure 1A). The presence of
altered CHMP2BmRNA, as formerly shown in Urwin et al.
(2010) was confirmed via qPCR and showed expression of
the intron 5 and delta-10 isoforms only in the patient
iPSC. These abnormal transcripts, generated via the
CHMP2B mutation affecting the slice acceptor site, are
completely absent in the isogenic controls (Figure 1A). All
iPSC and genetically corrected isogenic lines were deter-
mined to be karyotypically normal (Figure S1D).Differentiation of FTD3 iPSCs to Forebrain Cortical
Neurons
We employed a modified dual SMAD protocol (Figure 1B)
to generate forebrain-specific cortical neurons. Flow cy-
tometry analyses demonstrated the neural progenitor cell
(NPC) cultures to be comparable with respect to NESTIN
and SOX1 expression (Figure S2A). All NPCs expressed
the forebrain markers PAX6 and OTX2 (Figure S2B). ICC
revealed the majority of the matured neurons to be gluta-
matergic (immunopositive for VGlut1 [Figure S2C] and
co-positive for MAP2, TAU, and TUJ1 [Figure S2C]).
Approximately 10% of neurons were GABAergic (Fig-
ure S2C), while approximately 5% were GFAP-positive as-
trocytes, with a minor population (2%–3%) comprising
tyrosine hydroxylase-positive dopaminergic neurons (Fig-
ure S2C). Since quantification via ICC is challenging we
performed qPCR for TUJ1, VGlut1, and FOXG1 in order to
estimate the comparability in regard to the neural cell
composition of the investigated FTD3 iPSC- and isogenic
iPSC-derived neurons. All lines showed comparable
amounts of expression with no significant differences,
which is also indicative that the mutation in CHMP2B
does not affect the differentiation potential toward neu-
rons (Figure 1C). Neurons exhibited spiking activity and
action potentials, which occurred both spontaneouslyentiation, and Morphometric Analyses
sODN with silent mutation (SacII), sequencing results, and quan-
pression values were calculated as relative amount of mRNA versus
al Procedures for details). Scale bar, 200 mm for all. BFGF, basic
ctor; cAMP, cyclic AMP.
vels in FTD3 neurons (H150, H151, H242) and isogenic controls
periment, no significant differences were found among the different
age neurite length and soma size. n = 3 with three replicates in each
*p < 0.001.
AE
Mito Norm
Mito Cristaeless
1 μm
MitoTracker
FT
D
3
ne
ur
on
s
Is
og
en
ic
 c
on
tro
ls
H150
H150 ISO
H151 H242
H151 ISO H242 ISO
B
G
C
D
F
H
Top 10 endosome-associated genes differentially expressed
-6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6
WNT1
WNT3A
HFE
DYSF
CD4
CTSK
UTS2R
DAB2
APOE
HLA-DQB1
CAMK2A
ADRB2
CRHBP
ACPP
TYRP1
AVPR1B
EQTN
LRAT
AQP2
SLC30A2
n=63
n=30
Down
Up
Log2 fold change FTD3/ISO
Genome wide corrected
FDR 5%
Top 10 mitochondria-associated genes differentially expressed
-6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6
CCK
ME3
UCP1
ALB
IGF1
GADD45B
CCR7
P2RX7
NDUFA4L2
TMEM173
MAOB
GPAT2
COX6B2
NT5M
NDUFAF6
LRRK2
MGARP
PDE2A
SFN
HTR2C
n=42
n=26
Down
Up
Log2 fold change FTD3/ISO
Genome wide corrected
FDR 5%
Mito Total Mito Cristaeless
0.00
0.01
0.02
0.03
0.04
Relative mitochondria : cytoplasma area ratio
FTD3 neurons
Isogenic controls
Independent control
n.s.
n.s.
Endo total
0
1
2
3
Area of individual endosome
FTD3 neurons
Isogenic controls
Independent control
n.s.
n.s.
Endo total Endo L Endo M Endo D
0.00
0.02
0.04
0.06
0.08
0.10
Relative endosome : cytoplasma area ratio
FTD3 neurons
Isogenic controls
Independent control
n.s.
n.s.
n.s.
n.s.
1 μm
Endo L
Endo D
Endo M
(legend on next page)
Stem Cell Reports j Vol. 8 j 648–658 j March 14, 2017 651
and under current-clamp conditions (Figures S3B–S3D).
Measurement of intracellular calcium levels also demon-
strated that cultures exhibited neuronal functionality.
The neurons were responsive to the neurotransmitters
glutamate/glycine, GABA, and, to a lesser extent, acetyl-
choline (Figure S3A), and depolarization of the plasma
membrane by addition of potassium resulted in a small in-
crease in intracellular calcium (Figure S3A). Serotonin and
dopamine did not induce a change in intracellular calcium
levels. All lines showed similar responses.
FTD3 Neurons Display Aberrant Endosomes
Via transmission electron microscopy, we observed simi-
larly enlarged endosome (assessed as endosome-occupied
relative neuronal area, see the Supplemental Experimental
Procedures) in our FTD3 neurons, as previously demon-
strated in patients (Urwin et al., 2010) (Figure 2A). Such
enlarged endosomes were absent from the isogenic con-
trols, indicating a rescue of the phenotype by CRISPR/
Cas9-mediated gene correction and is consistent with pre-
vious knockdown experiments (Nielsen et al., 2012). Spe-
cifically, the electron-lucent and, thus, vacant endosomes
were significantly more abundant in the FTD3 neurons
(Figures 2B and 2C), indicative of an effect on early-stage
endosomes.
FTD3 Neurons Display Abnormal Mitochondria
Given that mitochondrial defects are commonly observed
in neurodegenerative diseases, we assessed whether such
a phenotype is evident in FTD3 neurons. While we noted
no apparent difference in size of mitochondria between
FTD3 neurons and their isogenic controls, we did observe
a significant increase in abnormal mitochondria with se-
vere impairment of cristae formation in FTD3 neurons
(Figures 2E and 2F). Strikingly, the distribution of mito-
chondria within neurons was also perturbed in FTD3 neu-Figure 2. FTD3 Neurons Exhibit Aberrant Endosome and Mitochon
(A and B) Stereology and ultrastructure of endosome in FTD3 neurons
control (black bar): (A) shows total size of endosome; (B) shows the ra
into electron-lucent (Endo L), medium electron-dense (Endo M), a
experiment, significant differences are indicated by *p < 0.05. n.s., n
(C) Transmission electron microscopy (TEM) images of Endo L, Endo M
(D) Total number of endosome-associated genes and the top ten differ
discovery rate (FDR) of 5%.
(E) Stereology and ultrastructure of mitochondria in FTD3 neurons (r
control (black bar): relative size of mitochondria compared with cyto
chondria; n = 3 with three replicates in each experiment, significant
(F) TEM images of normal and cristaeless mitochondria. Scale bar, 1 m
(G) Images of neurons dyed with the mitochondrial probe MitoTracke
mitochondria and the dashed line shows a representative distribution o
(H) Total number of mitochondria-associated genes and top ten diffe
FDR of 5%.
652 Stem Cell Reports j Vol. 8 j 648–658 j March 14, 2017rons: MitoTracker analyses revealed mitochondria in FTD3
neurons to preferentially localize to the perinuclear region,
while isogenic controls exhibited a homogeneous distribu-
tion throughout axons and dendrites (Figure 2G). Consis-
tent with previous studies correlating a lack of axonalmito-
chondria with axonal degradation (Rawson et al., 2014), we
also observed disorganized microtubule organization in
FTD3 neurons (Figure S4A). These findings were substanti-
ated by the fact that the average neurite length and soma
size were significantly reduced in FTD3 neurons versus
isogenic controls (Figure 1D).
FTD3 Neurons Display Impaired Mitochondria
Function and Increased Oxidative Stress
Prompted by our observations of aberrant mitochondrial
morphology, we sought to test the functionality of such
FTD3 mitochondria by assessing their basal respiration
rate, ATP-linked respiration, proton leak, and reserve ca-
pacity. Our analyses uncovered a reduced basal respiration
rate in FTD3 neurons as well as a reducedmaximal capacity
(Figure 3E). Consistent with mitochondrial dysfunction
manifesting in oxidative stress, we observed up to 20%
occurrence of oxidative stress in FTD3 neurons compared
with only 7% in isogenic controls (Figure 3A). Thus,
FTD3 neurons are exposed to higher levels of oxidative
stress, and targeted gene editing can reverse the disease
phenotype. Subsequently, we investigated whether the
increased oxidative stress impacts cell viability, but we de-
tected no evidence for increased apoptosis in FTD3 neu-
rons (Figure 3B).
Global Gene Expression Analyses Confirm Defects in
the Endosome, Mitochondrial Dysfunction, and
Increased Oxidative Stress
To obtain an overview of gene expression changes in
CHMP2B-dependent neurodegeneration, we performeddria
(red bar), isogenic controls (gray bar), and an independent healthy
tio of endosome to cytoplasm and further subdivision by appearance
nd electron-dense (Endo D); n = 3 with three replicates in each
ot significant.
, and Endo (D) Scale bar, 1 mm for all.
entially expressed genes (on the basis of fold-change) within a false
ed bar), isogenic controls (gray bar), and an independent healthy
plasmic area of all mitochondria (Mito total) and cristaeless mito-
differences are indicated by **p < 0.01, and ***p < 0.001.
m for both.
r (red) counterstained with DAPI (blue). Arrowheads indicate dyed
fmitochondria in an isogenic control neuron. Scale bar, 10mm for all.
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RNA-seq analyses, which revealed 3,205 differentially ex-
pressed genes in FTD3 neurons compared with their
isogenic controls. Heatmap analyses showed that neurons
derived from iPSCs of all three FTD3 individuals clustered
together, while isogenic controls clustered together with
the independent healthy individual (Figure 4A), suggesting
that the isogenic control lines reverted to a healthy control
gene expression profile after repair of the CHMP2B muta-
tion. To identify which cellular components are primarily
affected in FTD3 neurons, we performed gene ontology
(GO) term analysis. We found enrichment of the GO term
for postsynaptic membrane, synaptic membrane, neuron
projection, and synaptic vesicle membrane (Figure 4C),
and depletion of early endosome membrane, lysosomal
lumen, and endocytic vesicle membrane (Figure 4D).
With the aim to identify additional genes associated
with the main phenotypes observed in FTD3 neurons, we
extracted the top ten differentially regulated genes func-
tionally linked to neurodegeneration and associated with
endosomes (Figure 2D), mitochondria (Figure 2H), and
oxidative stress (Figure 3C). Strikingly,APOE ranked among
the ten most downregulated endosome-associated genes
(Figure 2D). APOE4, an isoform of APOE, is a well-known
risk factor for sporadic AD (sAD) (Corder et al., 1993) and,
consistent with a putative role in FTD3 pathophysiology,
some sAD patients present with enlarged early endosomes
(Cataldo et al., 2000).
Most interestingly, we observed an upregulation of
leucine-rich repeat kinase 2 (LRRK2) among the mitochon-
dria-related genes (Figure 2H). LRRK2 is one of the five
genes mutated in familial forms of PD. Previous studies
reported mitochondrial fragmentation due to increased
expression of LRRK2 (Wang et al., 2012), pointing to an
association between upregulated LRRK2 expression and
cristae dysgenesis in FTD3 neurons. LRRK2 was also de-
tected in the oxidative stress group (Figure 3C) and is upre-
gulated in some cases of sporadic PD (Cho et al., 2013)
accompanied by elevated levels of oxidative stress (Nguyen
et al., 2011). MPO and APOD, both implicated in AD (Fig-
ure 3C) (Maki et al., 2009; Martinez et al., 2012), were
strongly downregulated in FTD3 neurons.Figure 3. Impaired Mitochondrial Function and Oxidative Stress i
(A) CellROX green and SYTOX red flow cytometry assay of live oxidativ
significant differences are indicated by **p < 0.01 and ***p < 0.001
(B) CellEvent Caspase-3/7 green and SYTOX red flow cytometry assay
(C) Total number of oxidative stress-associated genes and the top ten
an FDR of 5%. n.s., not significant.
(D and E) Mitochondrial function profile of FTD3 neurons (H150, H151
(D) oxygen consumption rate (OCR) was measured before (basal) an
(trifluoromethoxy)phenylhydrazone (FCCP), and a mixture of rotenon
respiration parameters were calculated based on the OCR measurem
Procedures. n = 3 with three replicates in each experiment, significant
654 Stem Cell Reports j Vol. 8 j 648–658 j March 14, 2017Imbalance of Iron Homeostasis Represents a Unifying
Factor Linking Endosome, Mitochondrial
Dysfunction, and Oxidative Stress
Via our in silico analyses, we identified mis-expression of
genes encoding proteins or receptors known to be involved
in iron homeostasis. Among these were TRPC6 (12-fold up-
regulated), HFE (8-fold downregulated), and ABCG2, HP,
and CP (all 2-fold downregulated) (Figure 4B). A potential
imbalance of iron homeostasis might plausibly induce
intracellular ferrous iron (Fe2+) accumulation, damaging
mitochondria and inducing stress, to be further exacer-
bated by the defects in the endosome compartment
contributing to increased amounts of trapped Fe3+ within
endosomes (Figure 4E). Supporting this hypothesis, cyto-
plasmic Fe2+ levels are significantly increased in FTD3
neurons versus isogenic control neurons (Figure 4F). This
increase in intracellular iron was consistent in several
independent neural differentiation experiments, and the
increased expression in TRCP6was also confirmed viawest-
ern blot analysis (Figure 4B), further substantiating our hy-
pothesis for impaired iron homeostasis triggered by altered
expression and protein amounts of key regulators.
Taken together we have shown that FTD3 neurons have
enlarged early endosomes, display mitochondria dysfunc-
tion and perturbed iron homeostasis, with subsequent in-
crease in oxidative stress.DISCUSSION
The biological function of CHMP2B has primarily been
investigated in animal models, with the attendant caveat
that observed phenotypes are potentially species specific
or contributed to by transgene integration. Here, to pre-
clude such issues, we developed an FTD3 patient-derived
disease model by way of iPSCs generation, genome editing,
and in vitro neuronal differentiation techniques.
We identified enlargements of particularly the early endo-
some population in FTD3 neurons, indicating that per-
turbed endo-lysosomal fusion anddegradationof substrates
is key to the underlying FTD3 pathophysiology. Cellularn FTD3 Neurons
e stressed neurons. n = 3 with three replicates in each experiment,
.
of apoptotic neurons.
differentially expressed genes (on the basis of fold-change) within
and H242) and isogenic controls (H150 ISO, H151 ISO, H242 ISO).
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e (rot) and antimycin A (antimA), respectively; (E) mitochondrial
ents shown in (D) as described in the Supplemental Experimental
differences are indicated by *p < 0.05, **p < 0.01, and ***p < 0.001.
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components, including mitochondria, are degraded in the
endosome; in amyotrophic lateral sclerosis, a progressive
lysosomal deficit is causative for impaired degradation of
damaged mitochondria in motor neurons (Xie et al.,
2015). Defective recycling of large organelles, such as mito-
chondria, is the earliest detectable impairment in a chain of
events initiated by defective recycling (Cannizzo et al.,
2012), which clearly links endosome and mitochondrial
dysfunction.
FTD3 neurons displayed abnormal mitochondrial locali-
zation and cristae formation, manifesting in impaired
functionality typical for neurodegenerative diseases. Defec-
tive mitochondria show impaired ATP generation and
release of deleterious chemicals such as reactive oxygen
species (ROS), potentially inducing cell death. We contend
that increased ROS release contributes to increased organ-
elle damage, which cannot be appropriately ameliorated
through degradation owing to the observed endosome
defects, resulting in a self-perpetuating cycle of cellular
damage.
Strikingly, in FTD3 neurons we identified a robust, signif-
icant upregulation of LRRK2 encoding the dardarin pro-
tein. One function of dardarin is the modulation of
intracellular trafficking via recruitment of RAB7 (Greggio
et al., 2006). Mutant CHMP2B impairs the recruitment of
RAB7, crucial for endosome-lysosome fusion (Urwin
et al., 2010). This relationship between CHMP2B, RAB7,
and dardarin is supported by studies showing that dardarin
negatively regulates RAB7-dependent localization of the
lysosome (Dodson et al., 2012). Therefore, upregulation
of LRRK2 as a consequence of CHMP2B mutation might
contribute to deficient endo-lysosomal trafficking and
fusion. Dardarin also plays a role in mitochondrial func-
tionality and positioning, since induced expression of
wild-type LRRK2 induces mitochondrial fragmentation via
increased fission and upregulation of DLP1, which is crit-
ical for correct mitochondrial distribution (Wang et al.,
2012).
Furthermore, our analysis revealed APOE to be signifi-
cantly downregulated in FTD3 neural cells. The cells
analyzed via RNA-seq are a mixed population of neurons
and glial cells, with an up to 90% enrichment of VGlut1+Figure 4. Transcriptional Analysis of FTD3 Neurons Versus Isogen
(A) Heatmap and hierarchical clustering analysis of gene expression
(H150 ISO, H151 ISO, H242 ISO) as well as one independent healthy
(B) qPCR validation of genes of interest from RNA-seq results and we
(C and D) GO term enrichment analysis of differentially expressed gene
as nodes linked based on their kappa score level (R0.5), where only
size represents the term enrichment significance. Functionally relate
(E) Diagram of key dysregulated genes involved in intracellular iron h
(F) Fe2+ assay and concentration normalized to total cellular protein.n
are indicated by *p < 0.05.
656 Stem Cell Reports j Vol. 8 j 648–658 j March 14, 2017neurons. Due to this mixed population of cells we were still
able to detect APOE via RNA-seq, even though it is mainly
expressed in astrocytes. APOE is a major cholesterol carrier
in neurons that supports lipid transport and brain injury
repair, and there is a key requirement for APOE in facili-
tating the clearance of soluble amyloid beta (Abeta) (Jiang
et al., 2008). Furthermore, APOE suppresses microglia acti-
vation (Laskowitz et al., 2001), and reduced APOE levels
might potentially trigger inflammatory events. Together,
this suggests that downregulation of APOE in FTD3 neu-
rons might be a contributing factor in the microglia activa-
tion seen in postmortem FTD3 brains. Interestingly, we
observed another phenotype restricted to glial cells. It has
previously been reported for FTD3 mouse models and
patient brains that these display p62 inclusions, which
are indicative for impaired autophagy, oxidative stress,
and neurotoxicity (Ghazi-Noori et al., 2012; Holm et al.,
2007). We identified these p62 inclusions only in the
S100b+ glial cell population and not in our TUJ1+ neurons
(Figure S4B). Both the APOE and the p62 phenotypes
clearly show that, even though several disease features
can be replicated in our FTD3 neurons, other neural cell
types need to be investigated in the future to understand
the full complexity and pathophysiology of the disease.
Based on the differentially expressed key components
and increase of intracellular iron in FTD3 neurons, we pre-
sent an additional pathological feature of FTD3, which is
associated with an imbalance in iron homeostasis (Fig-
ure 4E). Iron uptake principally proceeds through iron
bound to transferrin mediated via the transferrin receptor
or via direct uptake of Fe2+ facilitated by a variety of recep-
tors including TRPC6 (Mwanjewe and Grover, 2004). We
propose that upregulation of TRPC6manifests in increased
uptake of Fe2+, while downregulation of HFE (which com-
petes with Tf), results in uptake of more ferric iron which
can further be reduced into Fe2+. In contrast, export of
heme-bound iron via ABCG2 or unbound Fe2+ through
FPN can be reduced. Concordant with this model, we
confirmed in several individual differentiation experi-
ments a small but significant increase of intracellular iron
within 5 weeks of neuronal differentiation in FTD3 neu-
rons. Excessive amounts of intracellular Fe2+ are toxic toic Controls and Quantification of Intracellular Fe2+ Content
profile of FTD3 neurons (H150, H151, H242) and isogenic controls
control (H256).
stern blot relative quantification of TRPC6 protein expression.
s via ClueGO v1.4 software. Functionally grouped network with terms
the label of the most significant term per group is shown. The node
d groups partially overlap.
omeostasis.
= 3 with three replicates in each experiment, significant differences
cells and trigger the production of ROS. Moreover, Fe2+ and
hydrogen peroxide engage in the so-called Fenton reaction,
producing ferric iron and highly reactive hydroxide, which
damages DNA, proteins, and lipids in the cell (Altamura
and Muckenthaler, 2009).
FTD3 neurons present with enlarged early endosomes,
increased cristaeless mitochondria, intracellular iron accu-
mulation, and oxidative stress. All of these phenotypes
were rescued via genetic correction of the CHMP2B
mutation.
We propose that in FTD3 neurons two events occur in
parallel: (1) mutant CHMP2B causes an imbalance in iron
homeostasis triggering mitochondrial impairment, which
consequently triggers ROS and neuronal damage, and (2)
mutant CHMP2B-dependent enlargement of endosomes,
which causes defects of the endo-lysosomal degradation
and recycling pathway, including recycling of receptors
for iron uptake, results in accumulation of defective
mitochondria, imbalanced iron homeostasis, ROS, and
neuronal damage. Future studies will determine the exact
role of mutant CHMP2B on a molecular level within these
cellular events.
In conclusion, our findings indicate a possibility of tar-
geting iron imbalances therapeutically in efforts to inter-
vene in this cycle of damage to attempt treatment of
FTD3. Furthermore, the CHMP2B-dependent human
iPSC-derived neurons can be added to the list of in vitro
cellular model systems that serve as a tool to study not
only common mechanisms of pathogenesis, such as mito-
chondrial defects and oxidative stress, but also the effects
of iron accumulation in neurodegenerative diseases.EXPERIMENTAL PROCEDURES
Cell Culture, iPSC Generation, and Neuronal
Differentiation
iPSCs were generated via episomal reprogramming (Addgene,
27077, 27078, 27080) from human dermal fibroblasts obtained
from skin biopsies. Neuronal differentiation followed a modified
dual SMAD protocol.Genome Editing
Generation of isogenic controls from the three FTD3 iPSC lineswas
achieved via the CRISPR/Cas9 system (Addgene, 62988) using sin-
gle-strand donor oligonucleotides as a template.Transmission Electron Microscopy
Cells were seeded on 13 mm Thermanox plastic coverslips
(Nunc, 174950) coated with poly-O-Lysine/laminin. Ultra-thin
(50–70 nm) sections were prepared, contrasted with 2% uranyl
acetate (PolyScience, 21447) and lead citrate, and examined us-
ing a Philips CM100 transmission electron microscope equipped
with a Morada camera.RNA-Seq Analysis
For deep RNA-seq, libraries of FTD3neurons, isogenic controls, and
an independent healthy controlwere prepared and sequenced on a
HiSeq 2000 Sequencing System (Illumina) following the manufac-
turer’s protocol.
Statistical Analysis
Data are presented as mean ± SE. n is the number of independent
differentiations of NPCs (from the cryobank) to neurons. Signifi-
cance of data was evaluated by Student’s t test or two-way
ANOVA with Bonferroni post hoc test. Unless noted otherwise,
p < 0.05 was considered statistically significant.
For further details on Experimental Procedures, see the Supple-
mental Information.
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